Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Knocking out IL-6 by vaccination.

Pia Galle1, Lotte Hougs, Torben Barington

  • 1Institute for Inflammation Research, Rigshospitalet National University Hospital, Copenhagen, Denmark.

European Journal of Immunology
|February 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the non-specific effects of BCG vaccination on the immune system and serological response to influenza vaccination in the elderly: A randomised controlled trial.

Vaccine·2026
Same author

Harnessing arginase 2-specific CD8+ T cells to target immunosuppressive cutaneous T-cell lymphoma.

The British journal of dermatology·2025
Same author

OMIP-115: High-Dimensional Phenotypic Characterization of Human Natural Killer Cells for Therapeutic Use.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025
Same author

Role of NK Cells in Progression and Treatment of Multiple Myeloma.

Frontiers in bioscience (Landmark edition)·2025
Same author

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level.

Journal of visualized experiments : JoVE·2025
Same author

The clinical landscape of CAR NK cells.

Experimental hematology & oncology·2025
Same journal

Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme.

European journal of immunology·2026
Same journal

Generation of Regulatory T Cells Against Islet Neoantigen.

European journal of immunology·2026
Same journal

Complement Inhibition in the Clinic: Are We Doing Enough to Protect Patients From Infection?

European journal of immunology·2026
Same journal

Special Issue: yEFIS 3rd Symposium.

European journal of immunology·2026
Same journal

CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16<sup>INK4A</sup> in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.

European journal of immunology·2026
Same journal

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

European journal of immunology·2026
See all related articles

Researchers developed a novel vaccination strategy using mutated IL-6 analogues to generate neutralizing antibodies against IL-6. This approach effectively induced a long-lasting IL-6 deficiency, blocking IL-6-mediated pathology in mice.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Interleukin-6 (IL-6) dysregulation is implicated in inflammatory diseases, degenerative conditions, and cancers.
  • Existing methods to block IL-6 receptor interactions are available.

Purpose of the Study:

  • To develop a simple and effective method for inducing a neutralizing antibody response against IL-6.
  • To investigate the potential of using mutated IL-6 analogues for vaccination.

Main Methods:

  • Vaccination of mice with a pool of specifically mutated IL-6 analogues.
  • Assessment of IL-6 analogue structure and binding affinity to IL-6 receptors and antibodies.
  • Evaluation of the induced antibody response and its effect on IL-6-mediated pathology.

Main Results:

Related Experiment Videos

  • The mutated IL-6 analogues possessed a three-dimensional structure similar to wild-type IL-6.
  • Vaccination successfully broke self-tolerance, inducing a robust anti-IL-6 antibody response.
  • This resulted in a sustained, antibody-mediated IL-6 deficiency that inhibited experimentally induced IL-6 pathology.

Conclusions:

  • Vaccination with mutated IL-6 analogues is a highly effective strategy for inducing neutralizing antibodies against IL-6.
  • This approach offers a promising method for blocking IL-6 activity and mitigating IL-6-driven diseases.